LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Video & Transcript
Capitol Directory (Beta)
US
Louisiana LA
Legislatures
2020 Regular Session
House
Bills
HB616
LA
Louisiana House Bill HB616
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Calendar
Louisiana 2020 Regular Session
Louisiana House Bill HB616
Introduced
2/28/20
Introduced
2/28/20
Refer
2/28/20
Refer
3/9/20
Refer
3/9/20
Caption
Provides for disclosure of prescription drug cost information
Latest LA HB616 Activity
View All Events: LA 2020 Regular Session HB616
Companion Bills
No companion bills found.
Previously Filed As
LA HB436
Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)
LA HB547
Prohibits penalties for disclosure by pharmacists of certain prescription drug cost information
LA SB0136
Disclosures related to prescription drugs.
LA SB62
Provides relative to the maximum cost of prescription insulin drugs. (8/1/20)
LA HB343
Lowering Prescription Drug Costs for Patients Act; enact
LA A3245
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
LA S323
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
LA A1646
Establishes prescription drug pricing disclosure requirements and measures to reduce prescription drug costs.
LA SB873
Prescription drugs: cost sharing.
LA H1509
Prescription Drugs
Similar Bills
MS SB2012
Mississippi Health Care Cost Transparency Act; enact.
TX HB2536
Relating to transparency related to drug costs.
RI H7245
The Drug Cost Transparency Act
MA H1176
Relative to promoting comprehensive transparency in the pharmaceutical industry
MA S732
Relative to promoting comprehensive transparency in the pharmaceutical industry
TX HB1033
Relating to prescription drug price disclosure; authorizing a fee; providing an administrative penalty.
CT HB05384
An Act Concerning Prescription Drug Costs.
LA HB436
Requires drug manufacturers to provide information regarding prescription drug prices (EN NO IMPACT See Note)